美国 · SEC FORM 4
Rapport Therapeutics, Inc.
RAPP · Nasdaq · CIK 0002012593 · Healthcare · Biotechnology
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
33 同一窗口内观察到的 Form 4 交易行
33 sales · 0 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-09-12 · Huber Reid M · $499.4K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出High
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Ceesay AbrahamChief Executive Officer
▼▼▼▼▼▼▼▼▼▼
TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.TenPercentOwner
▼▼▼▼
Yeleswaram KrishnaswamyChief Development Officer
▼▼▼
Gault CherylChief Operating Officer
▼▼
● 买入▼ 卖出○ 其他
—
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-09-12 · Huber Reid M.
近期 Form 4 活动
0买入
71卖出
4其他 Form 4 交易行
33SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出33 sale line(s) · 仅供背景
其他0 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,194,008
- 上期报告
- 2,248,069
- 日均成交量
- 660,098
- 回补天数
- 4.8
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-09-12 | PAUL STEVEN M | 买入 (P) | Common Stock | 41,666 | USD 24.65 | USD 1,027,107 | SEC 申报 ↗ |
| 2025-09-12 | Huber Reid M | 买入 (P) | Common Stock | 20,400 | USD 24.48 | USD 499,392 | SEC 申报 ↗ |
| 2025-09-11 | Young Wendy B. | 买入 (P) | Common Stock | 3,500 | USD 22.60 | USD 79,100 | SEC 申报 ↗ |
| 2025-03-13 | Ignelzi Troy A. | 买入 (P) | Common Stock | 100 | USD 9.98 | USD 998 | SEC 申报 ↗ |
| 2025-03-12 | Young Wendy B. | 买入 (P) | Common Stock | 6,000 | USD 10.21 | USD 61,260 | SEC 申报 ↗ |
| 2025-03-12 | Ignelzi Troy A. | 买入 (P) | Common Stock | 9,900 | USD 10.10 | USD 99,990 | SEC 申报 ↗ |
| 2024-07-01 | HEALY JAMES | 买入 (P) | Common Stock | 44,032 | USD 24.52 | USD 1,079,703 | SEC 申报 ↗ |
| 2024-06-10 | HEALY JAMES | 买入 (P) | Common Stock | 558,824 | USD 17.00 | USD 9,500,008 | SEC 申报 ↗ |
Form 4 申报证据
75 transaction lines in the latest 365-day window; 125 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-07 | Ceesay Abraham | 卖出 (S) | Common Stock | 1,147 | USD 30.66 | USD 35,167 | SEC 申报 ↗ |
| 2026-10-06 | Ceesay Abraham | 卖出 (S) | Common Stock | 3,375 | USD 32.03 | USD 108,106 | SEC 申报 ↗ |
| 2026-09-30 | Gault Cheryl | 卖出 (S) | Common Stock | 10,000 | USD 33.19 | USD 331,856 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-07 | Ceesay Abraham | 卖出 (S) | Common Stock | 1,147 | USD 30.66 | USD 35,167 | SEC 申报 ↗ |
| 2026-10-06 | Ceesay Abraham | 卖出 (S) | Common Stock | 3,375 | USD 32.03 | USD 108,106 | SEC 申报 ↗ |
| 2026-09-30 | Gault Cheryl | 卖出 (S) | Common Stock | 10,000 | USD 33.19 | USD 331,856 | SEC 申报 ↗ |
| 2026-09-23 | Ceesay Abraham | 卖出 (S) | Common Stock | 2,210 | USD 39.17 | USD 86,561 | SEC 申报 ↗ |
| 2026-09-08 | Ceesay Abraham | 卖出 (S) | Common Stock | 8,210 | USD 45.62 | USD 374,529 | SEC 申报 ↗ |
| 2026-08-25 | Yeleswaram Krishnaswamy | 卖出 (S) | Common Stock | 37,000 | USD 50.64 | USD 1,873,621 | SEC 申报 ↗ |
| 2026-08-25 | Ceesay Abraham | 卖出 (S) | Common Stock | 18,921 | USD 49.57 | USD 937,914 | SEC 申报 ↗ |
| 2026-08-24 | Yeleswaram Krishnaswamy | 卖出 (S) | Common Stock | 13,160 | USD 50.00 | USD 658,000 | SEC 申报 ↗ |
| 2026-08-19 | Yeleswaram Krishnaswamy | 卖出 (S) | Common Stock | 404 | USD 49.90 | USD 20,160 | SEC 申报 ↗ |
| 2026-08-11 | Ceesay Abraham | 卖出 (S) | Common Stock | 28,958 | USD 48.01 | USD 1,390,326 | SEC 申报 ↗ |
| 2026-08-10 | Ceesay Abraham | 卖出 (S) | Common Stock | 22,541 | USD 46.26 | USD 1,042,738 | SEC 申报 ↗ |
| 2026-07-27 | Ceesay Abraham | 卖出 (S) | Common Stock | 2,210 | USD 42.11 | USD 93,068 | SEC 申报 ↗ |
| 2026-07-14 | Ceesay Abraham | 卖出 (S) | Common Stock | 8,210 | USD 40.00 | USD 328,421 | SEC 申报 ↗ |
| 2026-06-30 | Gault Cheryl | 卖出 (S) | Common Stock | 10,000 | USD 41.58 | USD 415,770 | SEC 申报 ↗ |
| 2026-06-29 | Ceesay Abraham | 卖出 (S) | Common Stock | 8,220 | USD 39.83 | USD 327,409 | SEC 申报 ↗ |
| 2026-05-26 | TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P. | 卖出 (S) | Common Stock | 18,572 | USD 40.05 | USD 743,809 | SEC 申报 ↗ |
| 2026-05-11 | TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P. | 卖出 (S) | Common Stock | 133,618 | USD 40.24 | USD 5,376,788 | SEC 申报 ↗ |
| 2026-05-08 | TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P. | 卖出 (S) | Common Stock | 5,018 | USD 40.31 | USD 202,276 | SEC 申报 ↗ |
| 2026-05-07 | TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P. | 卖出 (S) | Common Stock | 271,495 | USD 40.12 | USD 10,892,379 | SEC 申报 ↗ |
| 2026-04-17 | Yeleswaram Krishnaswamy | 卖出 (S) | Common Stock | 20,225 | USD 39.99 | USD 808,798 | SEC 申报 ↗ |
| 2026-04-17 | TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P. | 卖出 (S) | Common Stock | 426,005 | USD 40.32 | USD 17,176,522 | SEC 申报 ↗ |
| 2026-04-14 | Yeleswaram Krishnaswamy | 卖出 (S) | Common Stock | 10,200 | USD 35.08 | USD 357,816 | SEC 申报 ↗ |
| 2026-04-13 | Yeleswaram Krishnaswamy | 卖出 (S) | Common Stock | 9,165 | USD 34.97 | USD 320,500 | SEC 申报 ↗ |
| 2026-04-10 | Yeleswaram Krishnaswamy | 卖出 (S) | Common Stock | 500 | USD 34.98 | USD 17,490 | SEC 申报 ↗ |
| 2026-04-08 | Yeleswaram Krishnaswamy | 卖出 (S) | Common Stock | 360 | USD 34.90 | USD 12,564 | SEC 申报 ↗ |
| 2026-03-30 | Gault Cheryl | 卖出 (S) | Common Stock | 10,000 | USD 28.18 | USD 281,848 | SEC 申报 ↗ |
| 2026-03-25 | Yeleswaram Krishnaswamy | 卖出 (S) | Common Stock | 10,115 | USD 29.99 | USD 303,349 | SEC 申报 ↗ |
| 2026-03-05 | Gault Cheryl | 卖出 (S) | Common Stock | 2,014 | USD 28.93 | USD 58,265 | SEC 申报 ↗ |
| 2026-02-19 | Bredt David | 期权行权／转换 (M) | Common Stock | 6,000 | USD 1.80 | USD 10,800 | SEC 申报 ↗ |
| 2026-02-18 | Ceesay Abraham | 卖出 (S) | Common Stock | 10,916 | USD 29.35 | USD 320,366 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | RAPP |
| CIK | 0002012593 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 125 transaction lines from 2024-06-10 to 2026-10-07 24 P purchase lines · 91 S sale lines · 10 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.